GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human transthyretin in complex with 2,6-dinitro- P-cresol (dnpc)

Analyse Crystal structure of human transthyretin in complex with 2,6-dinitro- P-cresol… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5L4F
Type
protein
Length
231 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
6J1, NA
Pockets
2 · best druggability 0.32

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1166% helix, 53% strandP02766
BTransthyretinprotein1156% helix, 53% strandP02766

Ligands and binding sites

  • 6J1 · 2,6-Dinitro-p-cresol · ligand · 2 copies · chains A, B
  • NA · Sodium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1740.320.7515empty
2500.310.7713empty

Interfaces

1 interface between chains.

  • A–B · 920 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 5L4F · Crystal Structure of Human Transthyretin in Complex with 2,6-Dinitro-p-cresol (DNPC) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.